| 產(chǎn)品名稱 | LY 2157299 - Galunisertib |
| 產(chǎn)品貨號 | Axon 1491 CAS [700874-72-2] MF C22H19N5OMW 369.42 Purity: 99% Soluble in 0.1N HCl(aq) and DMSO Description Orally active transforming growth factor β receptor (TGF-βR) kinase inhibitor under clinical development; IC50 values to be 86 nm (TβR1) and 2 nM (TβR2) respectively. KEYWORDS:?LY 2157299 | supplier | TGF-βR2 inhibitor | Galunisertib | LY2157299 | LY-2157299 | CAS [700874-72-2] | TGF-beta | transforming growth factor | TβR1 | TβR2 | antagonist | non-small cell lung cancer | NSCLC | Smad | pSmad |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
LY 2157299 - GalunisertibAxon 1491 CAS [700874-72-2] MF C22H19N5O
DescriptionOrally active transforming growth factor β receptor (TGF-βR) kinase inhibitor under clinical development; IC50 values to be 86 nm (TβR1) and 2 nM (TβR2) respectively. KEYWORDS:?LY 2157299 | supplier | TGF-βR2 inhibitor | Galunisertib | LY2157299 | LY-2157299 | CAS [700874-72-2] | TGF-beta | transforming growth factor | TβR1 | TβR2 | antagonist | non-small cell lung cancer | NSCLC | Smad | pSmad ? List of publications using LY 2157299 (Axon 1491) purchased from Axon Medchem
TGF-βR2 inhibitor
Chemical name4-[2-(6-Methyl-pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-quinoline-6-carboxylic acid amide Parent CAS No.[700874-72-2] |
| 產(chǎn)品資料 |
